This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
April 30, 2012 4:30 pm ET
Timothy L. Enns - Senior Vice President of Investor Relations, Business Development & Corporate Communications
James S. J. Manuso - Chairman of the Board and Chief Executive Officer
Michael Molkentin - Chief Financial Officer, Principal Accounting Officer and Corporate Secretary
Mohammad Azab - Chief Medical Officer
Harren Jhoti - Founder, Chief Executive officer and Director
Martin Buckland - Chief Business Officer and Director
Robin Davison - Edison Investment Research Limited
George B. Zavoico - McNicoll, Lewis & Vlak LLC, Research Division
Good day, ladies and gentlemen, and thank you for standing by here at Astex Pharmaceuticals First Quarter 2012 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. And now, I'll turn the program over to Timothy Enns, Senior Vice President Corporate Communications and Marketing. Sir, the floor is yours.
Timothy L. Enns
Thank you, operator. Good day and thank you for joining us for Astex Pharmaceuticals 2012 First Quarter Financial Results Conference Call. With me today are Dr. James Manuso, Chairman and Chief Executive Officer; Dr. Harren Jhoti, President and member of the Board of Directors; Dr. Mohammad Azab, Chief Medical Officer; Dr. Martin Buckland, Chief Business Officer; and Michael Molkentin, Chief Financial Officer. In a few moments, Jim Manuso and Michael Molkentin will deliver remarks on the 2012 first quarter financial results and our business outlook for the year. After prepared comments, we will open the line for questions. Earlier today, we issued a press release with our financial results. A copy of the press release is available in the Investor Relations section of our website at www.astx.com. In addition, this call is being webcast and may be accessed via the Investor Relations section of our website. A webcast replay will be available for 30 days.